Skip to main content
. 2024 Sep 19;12(9):1075. doi: 10.3390/vaccines12091075

Table 1.

Overview of scenarios utilized for the iFVVA.

# Name Presentation(s) Modeled Adoption Timing of MR-MAPs Coverage Assumption Used
N/S MAPs No Weighting Countries in Greatest Need Introduce Earlier High Low
1 No MR-MAPs with coverage increases x x
2 No MR-MAPs with stagnant coverage x x
3 MR-MAPs available with coverage increases x x x x
4 MR-MAPs available with stagnant coverage x x x x
5 MR-MAPs are implemented in countries with greatest need with coverage increases x x x x
6 MR-MAPs are implemented in countries with greatest need with stagnant coverage x x x x